in this issue
People & Business :: People/Executives
AMRI appoints William Marth as board chairman
4:39 AM MDT | June 6, 2013 | Deepti Ramesh
Albany Molecular Research Inc. (AMRI; Albany, NY) says its board of directors has unanimously voted to separate the role of chairman and CEO and has named William Marth, an active member of the AMRI board, as chairman of the board, effective 5 June 2013. The position of chairman has been held by Thomas D'Ambra, since the company's founding. D'Ambra retains his roles as a member of the board, president, and CEO. Marth was appointed to the AMRI board in 2012. Marth, formerly president and CEO of Teva – Americas, retired from Teva in 2012. He had...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee